DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization.
about
Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and futureTransarterial therapy: an evolving treatment modality of hepatocellular carcinomaThe role of interventional radiology in the management of hepatocellular carcinomaExtravascular use of drug-eluting beads: a promising approach in compartment-based tumor therapyTranscatheter embolization therapy in liver cancer: an update of clinical evidencesLocoregional drug delivery using image-guided intra-arterial drug eluting bead therapyTreatment of intermediate stage hepatocellular carcinoma: a review of intrahepatic doxorubicin drug-delivery systemsMultimodal Imaging of Nanocomposite Microspheres for Transcatheter Intra-Arterial Drug Delivery to Liver Tumors.A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular CarcinomaEffect of transcatheter intraarterial therapies on the distribution of Doxorubicin in liver cancer in a rabbit modelDoes drug-eluting bead transcatheter arterial chemoembolization improve the management of patients with hepatocellular carcinoma? A meta-analysisComparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beadsAlginate Microspheres Containing Temperature Sensitive Liposomes (TSL) for MR-Guided Embolization and Triggered Release of DoxorubicinMinimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?Hypoxia as a target for drug combination therapy of liver cancer.MRI visible drug eluting magnetic microspheres for transcatheter intra-arterial delivery to liver tumors.Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial.Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional studyProspective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.Development of "imageable" beads for transcatheter embolotherapy.Improved efficacy of transcatheter arterial chemoembolization using warmed miriplatin for hepatocellular carcinoma.Embolotherapy in the management of hepatocellular carcinoma.Hepatic arterial embolization with doxorubicin-loaded superabsorbent polymer microspheres in a rabbit liver tumor model.Transarterial chemoembolization with Doxorubicin-eluting microspheres for inoperable hepatocellular carcinoma.Transarterial embolisation of hepatocellular carcinoma with doxorubicin-eluting beads: single centre early experience.Systematic review comparing the safety and efficacy of conventional and drug-eluting bead transarterial chemoembolization for inoperable hepatocellular carcinoma.Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization.Doxorubicin-loaded drug-eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinomaHepatic arterial therapy with drug-eluting beads in the management of metastatic pancreatic carcinoma to the liver: a multi-institutional registry.Hepatic arterial therapy with drug-eluting beads in the management of metastatic bronchogenic carcinoma to the liver: a multi-institutional registry.Synthesis and characterisation of cationic quaternary ammonium-modified polyvinyl alcohol hydrogel beads as a drug delivery embolisation systemLiver cancer: Approaching a personalized care.Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine.Transcatheter intraarterial therapies: rationale and overviewAn Attempt to Shorten Loading Time of Epirubicin into DC Beads® Using Vibration and a Sieve.DC BeadM1™: towards an optimal transcatheter hepatic tumour therapy.Transarterial Chemoembolization of Child-A hepatocellular carcinoma: drug-eluting bead TACE (DEB TACE) vs. TACE with cisplatin/lipiodol (cTACE)Feasibility, safety and pharmacokinetic study of hepatic administration of drug-eluting beads loaded with irinotecan (DEBIRI) followed by intravenous administration of irinotecan in a porcine modelTranscatheter intra-arterial infusion of doxorubicin loaded porous magnetic nano-clusters with iodinated oil for the treatment of liver cancerEndovascular treatment of hepatocellular carcinoma with drug eluting microparticles (DC-Beads): CT evaluation of response to the treatment.
P2860
Q26771776-76B6D686-FCD8-4EA4-A6CF-265E6F5AC0FDQ26866514-603B3DAF-ECDD-4FD5-966E-7616B4BB41C4Q26996805-486EA551-785F-4542-810B-9C2DED51114AQ27000814-354E1477-111A-4C8B-8308-88CE714D7E26Q27003849-FE7C7D92-3603-48AB-A4EF-305D5390ACF0Q27015918-4C16B5E1-C0EE-493A-82B4-D99469227014Q27025606-BEEFCFCC-6F14-4131-9D40-1BD396ED58F9Q27329623-C904AD1B-9AD5-4F44-A1DF-92BA68FA5742Q28067517-CCD67B0D-1004-4765-9860-FFEC810AEF8EQ28534244-C9AB9281-0D1A-4524-A8E5-7C0D208AC1CDQ28541480-DD40B4B3-D4B9-4BC1-B0EB-0590529C32F2Q28542950-24BF51C8-6AFB-4ABD-8305-A0D24896C934Q28550901-3979E204-5378-4679-AEC1-4CE2674050B8Q30468280-15C12736-116D-425B-90B3-51B438E64369Q30491780-D9894883-DEA1-461C-8D35-63E12B4B4CC5Q30624761-042A8FA7-905B-4451-BF4F-B5B5418E78A0Q33414645-BE14759E-6A71-454A-9610-987CACC468FDQ33622783-FCAABF8A-9D02-4001-8B8D-449DDEFC3C67Q33631372-5468E156-C18B-4C48-A78E-AB9E5096DD22Q33876358-895E5D4C-65CE-416D-ACE0-27854FEB3925Q34233955-FDD7439B-8891-40A9-9A02-6ACFF4D64F1CQ34563655-12F990B0-BEC3-4CD0-8D7E-C6463F0F6E31Q34722614-DDCACC8B-E78E-42A6-AF40-56D7F48B7156Q34758857-24D025EB-B34B-4A86-951E-453DFCC6DF3EQ34991857-7DD54268-E154-4311-9298-5CCE2C1167EDQ35411599-33F44B3D-147A-4AAD-A997-7E79FE3E732AQ35672442-F8303050-32EC-459E-86A3-554D7571B316Q35682000-BC22D2F1-0809-4376-9091-C5D02EC77FEAQ35837917-86E8AF27-341A-4ABE-B597-019D30042715Q35864613-AD0857F5-EF6F-4354-871F-60432E23F4ACQ35898537-68C2CE1E-78F0-4724-A1B4-A8C33CA433EBQ35903794-E064B0C3-C3B8-4BFF-BA5C-54748EDFDABAQ35988578-83FA18E2-6B07-4F3A-859F-F0A42F328206Q36104314-731C1750-3775-4894-B3E7-B3B143ADEEBDQ36287137-EA61BA2D-85AF-404B-84ED-B1BC4643BEDFQ36378569-2B4F1F69-B9C7-4D9F-A7E1-D4270EA0AA8DQ36516386-024EDEC6-F87E-43C6-AF1D-CA9C6F6E7A04Q36518832-845161AC-4DD2-4139-ABA2-ADCE4A56F6E7Q36689688-96AE64F9-5D9F-441C-A709-785353C9F55FQ37183195-3AF327C1-C847-477F-9F7F-4DAB2784DE30
P2860
DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
DC bead: in vitro characteriza ...... ansarterial chemoembolization.
@ast
DC bead: in vitro characteriza ...... ansarterial chemoembolization.
@en
DC bead: in vitro characteriza ...... ansarterial chemoembolization.
@nl
type
label
DC bead: in vitro characteriza ...... ansarterial chemoembolization.
@ast
DC bead: in vitro characteriza ...... ansarterial chemoembolization.
@en
DC bead: in vitro characteriza ...... ansarterial chemoembolization.
@nl
prefLabel
DC bead: in vitro characteriza ...... ansarterial chemoembolization.
@ast
DC bead: in vitro characteriza ...... ansarterial chemoembolization.
@en
DC bead: in vitro characteriza ...... ansarterial chemoembolization.
@nl
P2093
P1476
DC bead: in vitro characteriza ...... ransarterial chemoembolization
@en
P2093
Brenda Hall
Laura C Wolfenden
M Victoria Gonzalez
Peter W Stratford
Rosemary R Palmer
Sean L Willis
Simon W Leppard
Yiqing Tang
P304
P356
10.1097/01.RVI.0000195323.46152.B3
P433
P577
2006-02-01T00:00:00Z